CVS Health Payor Solutions
Payor Solutions
Main menu
Biosimilars
About
Our Story
Who We Serve
Integrated Assets
Insights
All Insights
Care Management
Cost Management
Drug Pipeline
Government Programs & Services
Health Equity
Innovation
Public Policy
Specialty
Women's Health
Contributors
Programs & Services
Overview
Cost Management
Formulary Management
Network Strategies
Hyperinflation
Gene Therapy Solutions
Member Affordability
Specialty Management
Specialty Cost Management
Medical Benefit Solutions
Transform Oncology Care
Patient Care
Care Management
Member Engagement
Onboarding
Benefit Plan Changes
Health Plan Client Engagement
Shortcuts
Contact Us
Resources
Videos
News
Webinars
Events
Other Sites
Client Care Access
CVS Health
CVS Caremark
CVS Specialty
CVS Pharmacy
CVS MinuteClinic
Search form
Search
“Pipeline”
41 result(s)
Format
All Formats
Briefing
Commentary
Feature
Infographic
Specialty Report
Video
White Paper
Sort by
Most Recent
Most Popular
Drug Pipeline
Promising Treatments for Alopecia Areata in the Pipeline
New Treatments for Alopecia Areata on the Horizon
More
Briefing
Specialty
Managing the MS Cost Challenge
Multiple Sclerosis is a $19 billion market worldwide, and the third most expensive specialty drug spend category. Recently approved Ocrevus is likely to add to cost of treatment...
More
Briefing
Drug Pipeline
Keeping an Eye on the Drug Pipeline
New Drugs for Ophthalmic Disorders on the Horizon
More
Briefing
Health Equity
Marketplace Trends Shape Specialty Landscape
...
More
Briefing
Specialty
Three Major Challenges Facing Gene Therapy
The Top Challenges Facing Gene Therapy Today
More
Briefing
Drug Pipeline
A Q2 2022 Look at Projected Gene Therapies and Approval Timelines
A Q2 2022 Look at Projected Gene Therapies and FDA Approval Timelines
More
Briefing
Cost Management
Strategy and Balance: Managing Costs for Pulmonary Arterial Hypertension
Managing Treatment Costs for Pulmonary Arterial Hypertension
More
Briefing
Cost Management
A Breath of Fresh Air for Patients with Pulmonary Arterial Hypertension
New Dry Powder Inhalation Therapies for PAH in Pipeline
More
Briefing
Specialty
The Role of Biosimilars in Lowering Specialty Costs
Biosimilars Can Be Part of a Strategy to Lower Specialty Drug Costs
More
Briefing
Drug Pipeline
Treatment Options Expand in Robust Gene Therapy Pipeline
New Gene Therapies for Sickle Cell Disease, Hemophilia on the Horizon
More
Briefing
Load More